Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
1 drug for “Non Alcoholic Steatohepatitis (NASH)”
Approved 1
- Obeticholic acidINTERCEPT PHARMACEUTICALS, INC.Non Alcoholic Steatohepatitis (NASH)
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.